Diversis Capital Merges Genesis Automation Healthcare, Kermit, and Meperia

November 12, 2025
Diversis Capital has merged Genesis Automation Healthcare, Kermit, and Meperia into a unified entity under the Genesis Automation Healthcare brand, creating an AI-enabled platform for hospital supply chain and inventory management.

Diversis Capital has completed the acquisitions of Genesis Automation Healthcare, Kermit, and Meperia, announced in a press release. The three companies will operate under the Genesis Automation Healthcare brand to form what is described as the first end-to-end healthcare supply chain and inventory management platform.

According to the announcement, the combined platform will provide inventory and spend management solutions for hospitals, health networks, and ambulatory surgery centers. It currently serves over 100 organizations worldwide and is expected to deliver more than $1 billion in annual procurement savings.

The new Genesis platform will integrate cloud and AI technologies to unify clinical supply chain workflows, clean and standardize item data, and connect with hospital ERP and EHR systems. The company aims to address inefficiencies and compliance risks in healthcare supply management while reducing administrative burdens on clinical staff.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

11/12
ABK Biomedical Raises $35 Million in Series D Funding Led by J.P. Morgan Life Sciences
11/12
CampusKnot Raises $1.1 Million to Expand AI Teaching Assistant Platform
11/11
Gamma Raises $68 Million at $2.1 Billion Valuation, Surpasses $100 Million ARR
11/11
Automation Anywhere Acquires Aisera to Expand Agentic Automation Portfolio
11/11
RAAAM Memory Technologies Raises $17.5 Million to Advance Low-Power Chip Development

More from: Life Sciences

11/12
AI CoLab Hosts Second Annual 'AI for Health' Summit in Washington
11/12
SOPHiA GENETICS and Element Biosciences Integrate AI and Sequencing Platforms for Precision Medicine Research
11/12
Global Health Leaders Outline AI-Driven Roadmap at Future of Health Summit
11/12
CereCore Joins Oracle Partner Program to Expand Healthcare IT Services
11/12
Supreme Group Names Olly Johnston EVP of Platform Growth and Transformation

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like